Dr. Anan Chongkaewwatana virologist Director of Animal Health and Management Innovation Research Group National Center for Genetic Engineering and Biotechnology (Biotech), National Science and Technology Development Agency (NSTDA) posted on Facebook. Anan Jongkaewwattana Guidelines for immune testing after vaccination “Pfizer” It is a booster vaccine, stating that
A research team from the Francis Crick Institute in England published a paper in the Lancet today on immune levels.
Inhibition of omikron after third dose stimulation with Pfizer mRNA vaccine was found that at 3 weeks the level of omikron inhibitory antibody was as high as Delta-inhibiting antibody levels after 2 doses of PZ … The research team therefore took the PZx2 vaccine efficacy figure per delta.
Compared to Omikron data, PZx2 protects Delta up to nearly 90%, while Pzx3 only protects 65-70% Omikron, and that figure drops below 60% in 1-2 weeks.
Dr. Anan added that Research results after vaccination “Pfizer” of England stated that because most people who received Pzx3 in England were elderly This may cause differences in vaccine efficacy. In addition, there is a high probability that The omicron attached to the upper airway cells was much better than the delta. This puts a higher need for antibodies to prevent infection.
Antiviral antibody values are commonly used by researchers to refer to vaccine efficacy. But that’s not a direct number of vaccine efficacy, other factors such as age, immune status, or viral properties for drug resistance. Contribute to numbers…referring to the above numbers from the laboratory, so be very careful at this point.
